Clinical Trial Update: Intracochlear Injection of Glucocorticoid [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for intracochlear glucocorticoid injection in Sudden sensorineural hearing loss, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sudden Sensorineural Hearing Loss

Drugs mentioned

• Glucocorticoid (glucocorticoid)

Snippet

Sponsor: Eye & ENT Hospital of Fudan University | Conditions: Sudden Sensorineural Hearing Loss (SSNHL) | Phase 2 | Status: NOT_YET_RECRUITING